Gray Matter Atrophy in Multiple Sclerosis
GRAY MATTER ATROPHY IN MULTIPLE SCLEROSIS
Gray Matter Atrophy in Multiple Sclerosis
The measurement of gray matter pathology appears to be of growing clinical relevance as a biomarker of the multiple sclerosis (MS) disease process. Concepts about the evaluation, pathogenesis and clinical relevance of gray matter pathology in multiple sclerosis (MS) continue to evolve. A variety of […]
